On Monday I looked at three ASX shares that brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:
A2 Milk Company Ltd (ASX: A2M)
According to a note out of Credit Suisse, its analysts have resumed coverage on this infant formula and fresh milk company's shares with an underperform rating and $7.15 price target. The broker notes that Chinese birth rates are falling, which it fears could soon lead to a contraction in the infant formula industry in the lucrative market. It believes this could weigh on a2 Milk's profit growth in the future. The a2 Milk share price is fetching $8.04 on Tuesday.
Mayne Pharma Group Ltd (ASX: MYX)
A note out of Macquarie reveals that its analysts have downgraded this pharmaceutical company's shares to an underperform rating with an improved price target of 38 cents. The broker made the move partly on valuation grounds after some strong recent gains. And while Macquarie sees positives in the approval of its combined oral contraceptive Nextstellis in the United States, it isn't enough to become more positive. Particularly given its belief that near term trading conditions will remain subdued. The Mayne Pharma share price is trading at 46.5 cents this morning.
Sydney Airport Holdings Pty Ltd (ASX: SYD)
Another note out of Credit Suisse reveals that its analysts have retained their underperform rating but lifted their price target on this airport operator's shares to $5.30. According to the note, the broker has increased its estimates to reflect the positive impact of the ANZ travel bubble on passenger volumes. It notes that this particular route accounted for 7% of passengers prior to the pandemic. However, even after making these adjustments, it still feels its shares are expensive at the current level. Especially given the risk associated with the roll out of COVID-19 vaccines. The Sydney Airport is currently fetching $6.06.
